Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBrigham and Women's Hospital
About this trial
This is a master protocol for a prospective Phase I-II study evaluating feasibility and efficacy of incorporating magnetic resonance imaging (MRI) simulation into the planning of radiation treatments.
Eligibility criteria
Qualifiers
Participants must have a confirmed malignancy requiring radiation therapy.
Age: 18 years or older
ECOG performance status ≤2 (Karnofsky ≥60%, see Appendix A)
Ability to understand and the willingness to sign a written informed consent document.
Disqualifiers
For MRI involving contrast, history of allergic reactions attributed to gadolinium based IV contrast. Note: If patient will not receive contrast, this is not applicable
Participants who cannot undergo an MRI
Disease-specific exclusion criteria will be specified in the appropriate subprotocol
Trial design
Treatments tested in this trial
- MRI Simulator
- Radiation Therapy
Treatment groups
86 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov